2011Chin J Postgrad MedRequires access

Comparison of the effects of atorvastatin 10 mg or simvastatin 20 mg on serum lipids and inflammatory index in Tibetan type 2 diabetic patients with dyslipidemias

邬云红, 唐蜀西, 达娃普尺

Open publisher page 0 citations

Abstract

Objective To evaluate the effects of atorvastatin 10 mg or simvastatin 20 mg on serum lipids and high sensitive C-reactive protein (hs-CRP) in Tibetan type 2 diabetic patients with dyslipidemias.Methods Seventy Tibetan type 2 diabetic patients with dyslipidemias were divided into two groups by random number table: atorvastatin 10 mg group(35 cases,treated with atorvastatin 10 mg/d) and simvastatin 20 mg group (35 cases, treated with simvastatin 20 mg/d). Before and 4 weeks after treatment, total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), triglyceride (TG), apolipoprotein B (ApoB), white blood cell (WBC) count, fasting blood glucose (FBG) and hs-CRP were measured and adverse reactions were observed. Results After treatment for 4 weeks, the levels of TC, LDL-C and ApoB were significantly decreased in two groups (P< 0.01 ), and the level of TG was significantly decreased in atorvastatin 10 mg group [( 1.39 + 0.63 ) mmol/L vs. ( 1.95 ±1.62) mmol/L,P<0.05], but was not significantly decreased in simvastatin 20 mg group [(1.72 ±0.32)mmol/L vs. ( 1.93 ± 0.83 ) mmol/L,P > 0.05]. The level of hs-CRP was significantly decreased in two groups (P < 0.05), and the decreased range in atorvastatin 10 mg group was higher than that in simvastatin 20 mg group (40.51% vs. 35.34% ,P < 0.05). Stepwise regression analysis showed that the decreased hs-CRP was independent of reduced serum lipids and had relationship with the kinds of statins (B =-0.384,P=0.022).Conclusions The effects of simvastatin on serum TC, LDL-C are the same as atorvastatin. Both have significant anti-inflammatory effects, while the degree of hs-CRP reducing by atorvastatin 10 mg is higher than that by simvastatin 20 mg in Tibetan type 2 diabetes. Key words: Dyslipidemias;  Zang nationality;  C-reactive protein;  Atorvastatin;  Simvastatin

About this research paper

What this paper is about

Objective To evaluate the effects of atorvastatin 10 mg or simvastatin 20 mg on serum lipids and high sensitive C-reactive protein (hs-CRP) in Tibetan type 2 diabetic patients with dyslipidemias.Methods Seventy Tibetan type 2 diabetic patients with dyslipidemias were divided into two groups by random number table: atorvastatin 10 mg group(35 cases,treated with atorvastatin 10 mg/d) and simvastatin 20 mg group (35 cases, treated with simvastatin 20 mg/d). Before and 4 weeks after treatment, total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), triglyceride (TG), apolipoprotein B (ApoB), white blood cell (WBC) count, fasting blood glucose (FBG) and hs-CRP were measured and adverse reactions were observed. Results After treatment for 4 weeks, the levels of TC, LDL-C and ApoB were significantly decreased in two groups (P< 0.01 ), and the level of TG was significantly decreased in atorvastatin 10 mg group [( 1.39 + 0.63 ) mmol/L vs. ( 1.95 ±1.62) mmol/L,P<0.05], but was not significantly decreased in simvastatin 20 mg group [(1.72 ±0.32)mmol/L vs. ( 1.93 ± 0.83 ) mmol/L,P > 0.05]. The level of hs-CRP was significantly decreased in two groups (P < 0.05), and the decreased range in atorvastatin 10 mg group was higher than that in simvastatin 20 mg group (40.51% vs. 35.34% ,P < 0.05). Stepwise regression analysis showed that the decreased hs-CRP was independent of reduced serum lipids and had relationship with the kinds of statins (B =-0.384,P=0.022).Conclusions The effects of simvastatin on serum TC, LDL-C are the same as atorvastatin. Both have significant anti-inflammatory effects, while the degree of hs-CRP reducing by atorvastatin 10 mg is higher than that by simvastatin 20 mg in Tibetan type 2 diabetes. Key words: Dyslipidemias;  Zang nationality;  C-reactive protein;  Atorvastatin;  Simvastatin

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the effects of atorvastatin 10 mg or simvastatin 20 mg on serum lipids and high sensitive C-reactive protein (hs-CRP) in Tibetan type 2 diabetic patients with dyslipidemias.Methods Seventy Tibetan type 2 diabetic patients with dyslipidemias were divided into two groups by random number table: atorvastatin 10 mg group(35 cases,treated with atorvastatin 10 mg/d) and simvastatin 20 mg group (35 cases, treated with simvastatin 20 mg/d). Before and 4 weeks after treatment, total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), triglyceride (TG), apolipoprotein B (ApoB), white blood cell (WBC) count, fasting blood glucose (FBG) and hs-CRP were measured and adverse reactions were observed. Results After treatment for 4 weeks, the levels of TC, LDL-C and ApoB were significantly decreased in two groups (P< 0.01 ), and the level of TG was significantly decreased in atorvastatin 10 mg group [( 1.39 + 0.63 ) mmol/L vs. ( 1.95 ±1.62) mmol/L,P<0.05], but was not significantly decreased in simvastatin 20 mg group [(1.72 ±0.32)mmol/L vs. ( 1.93 ± 0.83 ) mmol/L,P > 0.05]. The level of hs-CRP was significantly decreased in two groups (P < 0.05), and the decreased range in atorvastatin 10 mg group was higher than that in simvastatin 20 mg group (40.51% vs. 35.34% ,P < 0.05). Stepwise regression analysis showed that the decreased hs-CRP was independent of reduced serum lipids and had relationship with the kinds of statins (B =-0.384,P=0.022).Conclusions The effects of simvastatin on serum TC, LDL-C are the same as atorvastatin. Both have significant anti-inflammatory effects, while the degree of hs-CRP reducing by atorvastatin 10 mg is higher than that by simvastatin 20 mg in Tibetan type 2 diabetes. Key words: Dyslipidemias;  Zang nationality;  C-reactive protein;  Atorvastatin;  Simvastatin

Key concepts: Simvastatin, Atorvastatin, Internal medicine, Triglyceride, Apolipoprotein B, Endocrinology, Blood lipids, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparison of the effects of atorvastatin 10 mg or simvastatin 20 mg on serum lipids and inflammatory index in Tibetan type 2 diabetic patients with dyslipidemias — Research Paper | ScholarLens